| SONN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SONN shares outstanding history going back to 4/2/2020:
Also see: SONN Market Cap History SONN YTD Return |
SONN Shares Outstanding History — Sonnet BioTherapeutics Holdings Share Count Over Time
As of 8/11/2025 Sonnet BioTherapeutics Holdings has 6.75 million SONN shares outstanding. Investors often track the SONN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SONN share count trends over time, with 23 historical shares outstanding datapoints presented, dating back to 4/2/2020.
| SONN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
SONN Historical Shares Outstanding: +603.21% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| SONN Stock Price Chart |
| About Sonnet BioTherapeutics Holdings Inc |
| Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company with a proprietary platform for biologic medicines of single-or bifunctional action. Its technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. It designed the FHAB construct to improve drug accumulation in tumors, and to extend the duration of activity in the body. Its lead asset, SON-1010, is a fully human single-chain version of Interleukin 12, covalently linked to the FHAB construct, for which it is pursuing clinical development in solid tumors. We show 23 historical shares outstanding datapoints in our coverage of SONN's shares outstanding history. Understanding the changing numbers of SONN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SONN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SONN by allowing them to research SONN shares outstanding history as well as any other stock in our coverage universe. |
| SONN Current Stock Quote |
Quotes delayed 20 minutes  Free SONN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SONN Share Performance |
| Shares Outstanding Peers |
| Sonnet BioTherapeutics Holdings (SONN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SONX Shares Outstanding History SPEX Shares Outstanding History SPNE Shares Outstanding History SPPI Shares Outstanding History SPRB Shares Outstanding History SPRO Shares Outstanding History SPRY Shares Outstanding History SQL Shares Outstanding History SQZ Shares Outstanding History SRDX Shares Outstanding History More Healthcare companies » |
SONN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
